|Mr. Marc N. Casper||CEO, Pres & Director||6.71M||63.94M||1968|
|Mr. Stephen Williamson||Sr. VP & CFO||1.7M||1.6M||1967|
|Mr. Mark P. Stevenson||Exec. VP & COO||3M||N/A||1963|
|Mr. Gregory J. Herrema||Sr. VP & Pres of Customer Channels||1.62M||6.06M||1966|
|Mr. Peter E. Hornstra||VP & Chief Accounting Officer||N/A||N/A||1960|
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis equipment; laboratory plastics and chemicals; and pharma services. It has a strategic collaboration with NX Prenatal Inc., Evosep, and Cedars-Sinai; research collaboration with Predictive Laboratories; strategic manufacturing collaboration with Amicus Therapeutics, Inc.; and collaboration with Owlstone Medical. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of October 4, 2019 is 6. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 5; Compensation: 8.